Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Stephanie S Yee
Affiliation
University of Pennsylvania
ORCID
Career Start Year
2010
Papers
36
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36689092
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Breast Cancer Res Treat
2023
36322403
Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.
Oncotarget
2022
35811459
Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expression.
Clin Transl Med
2022
35939771
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.
JCO Precis Oncol
2022
33067248
THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.
Cancer Prev Res (Phila)
2021
33615225
Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma.
Neurooncol Adv
2021
34733417
THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.
Oncotarget
2021
34454115
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.
J Mol Diagn
2021
34095713
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.
JCO Precis Oncol
2021
33976268
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors.
Sci Rep
2021
32140683
Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma.
Neurooncol Adv
2020
31666247
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.
Clin Cancer Res
2020
32102950
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.
Clin Cancer Res
2020
32299821
A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res
2020
30325992
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
JAMA Oncol
2019
31489121
Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.
Oncotarget
2019
31217895
Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.
Oncotarget
2019
30842658
Hepatocytes direct the formation of a pro-metastatic niche in the liver.
Nature
2019
30642547
Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.
Lung Cancer
2019
28786531
Feasibility of monitoring advanced melanoma patients using cell-free DNA from plasma.
Pigment Cell Melanoma Res
2018
30549400
An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.
Cytometry A
2018
29568081
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters.
Sci Rep
2018
29735554
miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer.
Cancer Res
2018
28653249
Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
Breast Cancer Res Treat
2017
28500398
Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer.
Breast Cancer Res Treat
2017
29019651
Combining Machine Learning and Nanofluidic Technology To Diagnose Pancreatic Cancer Using Exosomes.
ACS Nano
2017
28809985
A magnetic micropore chip for rapid (<1 hour) unbiased circulating tumor cell isolation and in situ RNA analysis.
Lab Chip
2017
28819852
Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.
Methods Mol Biol
2017
27468416
A novel approach for next-generation sequencing of circulating tumor cells.
Mol Genet Genomic Med
2016
27601595
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA.
Clin Cancer Res
2016
24634144
Comprehensive analysis of gene expression in human retina and supporting tissues.
Hum Mol Genet
2014
23098370
Matrix metalloproteinases and educational attainment in refractive error: evidence of gene-environment interactions in the Age-Related Eye Disease Study.
Ophthalmology
2013
24227913
Regional replication of association with refractive error on 15q14 and 15q25 in the Age-Related Eye Disease Study cohort.
Mol Vis
2013
23498719
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Lancet Oncol
2013
21859326
Acute biological effects of simulating the whole-body radiation dose distribution from a solar particle event using a porcine model.
Radiat Res
2011
20235421
Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy.
J Support Oncol
2010
1 - 36 of 36
Column Actions
Search
Recommended Authors
John Simmons
Personal Genome Diagnostics Inc.
Career Start Year
2016
Number of shared co-authors
0
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Stephanie J Yaung
Roche Sequencing Solutions Inc.
Career Start Year
2011
Number of shared co-authors
0
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year
2009
Number of shared co-authors
1
Xinmin Li
University of California los angeles
Career Start Year
2008
Number of shared co-authors
0
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year
2008
Number of shared co-authors
0
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
0
Arezou A Ghazani
Brigham and Women's Hospital, USA Harvard Medical School
Career Start Year
2006
Number of shared co-authors
1
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Career Start Year
2006
Number of shared co-authors
0
AmirAli Talasaz
University of California San Diego Moores Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year
2006
Number of shared co-authors
1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year
2005
Number of shared co-authors
0
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
0
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Career Start Year
2004
Number of shared co-authors
0
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
3
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
0
David T Miyamoto
Massachusetts General Hospital
Career Start Year
2000
Number of shared co-authors
1
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
0
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year
2000
Number of shared co-authors
3
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year
2000
Number of shared co-authors
1
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year
1999
Number of shared co-authors
0
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year
1999
Number of shared co-authors
1
Charles Swanton
Francis Crick Institute
Career Start Year
1997
Number of shared co-authors
2
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
1
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year
1996
Number of shared co-authors
3
Donald J Johann
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Career Start Year
1996
Number of shared co-authors
0
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year
1995
Number of shared co-authors
0
Aaron M Newman
Stanford University
Career Start Year
1994
Number of shared co-authors
0
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year
1989
Number of shared co-authors
0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Co-authored papers
3
Brian M Feldman
Co-authored papers
3
Zev A Binder
Co-authored papers
3
Seyed Ali Nabavizadeh
Co-authored papers
3
Rebecca Nagy
Guardant Health Inc.
Co-authored papers
2
Jeffrey B Ware
Co-authored papers
2
Timothy W Corson
Indiana University School of Medicine
Co-authored papers
1
Scott J Bornheimer
Co-authored papers
1
Jian-Bing Fan
Nanfang Hospital and Basic Medical College, Southern Medical University
Co-authored papers
1
Mingyao Li
Co-authored papers
1
Junhyong Kim
Co-authored papers
1
Claude Houdayer
INSERM U1245
Co-authored papers
1
Josephine C Dorsman
Cancer Center Amsterdam
Co-authored papers
1
Nadia L Prigoda
Toronto Western Hospital
Co-authored papers
1
Brigitte L Th??riault
Ontario Institute for Cancer Research, University Avenue
Co-authored papers
1
Elena Helman
Co-authored papers
1
Qi Long
and Informatics Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Roseline Godbout
University of Alberta
Co-authored papers
1
Michael L Kochman
Co-authored papers
1
Andrew J Cucchiara
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers
1
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Co-authored papers
1
Diane Rushlow
Toronto Western Hospital
Co-authored papers
1
Clarellen Spencer
Ontario Cancer Institute/Princess Margaret Hospital, University Health Network
Co-authored papers
1
Shannon Harmon
Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine
Co-authored papers
1
Berber M Mol
VU University Medical Center
Co-authored papers
1
Brenda L Gallie
The Eye Cancer Clinic, Princess Margaret Cancer Centre, Hospital for Sick Children
Co-authored papers
1
Amrita Basu
University of California San Francisco
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
Ann L Oberg
Co-authored papers
1
Judy C Boughey
Mayo Clinic
Co-authored papers
1
1 - 30